# Champions Oncology

Source: https://onco.cc/companies/champions-oncology/  
OnCo record `champions-oncology` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Oncology CRO with the largest bank of patient-derived xenograft models (TumorGraft), now adding 3D organoid screening and radiopharmaceutical services.

## Summary

Champions Oncology, based in Hackensack, New Jersey, and listed as CSBR, is an oncology contract research organisation with the largest bank of patient-derived xenograft models, called TumorGraft, now adding three-dimensional organoid screening and radiopharmaceutical services. It holds more than 1,400 clinically annotated PDX models correlated with patient outcomes, runs the TumorGraft3D organoid platform and reported record fiscal 2026 revenue of 59.4 million dollars with positive adjusted EBITDA. OnCo links it to patient-derived xenografts and organoids, to the bottleneck of preclinical models that do not predict people, and to the idea of running the mouse or organoid trial alongside the human trial. Whether annotated PDX banks predict clinical results better than cell lines is the question its business rests on. The PDX technology page carries the evidence.

## Fields

- Kind: Company
- Last checked: 2026-09-04
- HQ: Hackensack, NJ
- Type: cro-services
- Website: https://www.championsoncology.com
- Ticker: CSBR

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Champions_Oncology
- Company site: https://www.championsoncology.com/

## Connected records

- fronts: [Drug Discovery Platforms](https://onco.cc/fronts/drug-discovery/)
- technologies: [Patient-derived organoids](https://onco.cc/technologies/organoids/), [Patient-derived xenografts](https://onco.cc/technologies/pdx-models/)
- bottlenecks: [Lab models that fail to predict what happens in patients](https://onco.cc/bottlenecks/b-preclinical-models/)
- ideas: [Humanised mice with an immune system matched to the tumour donor](https://onco.cc/ideas/idea-bio1-immune-matched-humanised-mice/), [Multi-laboratory preclinical trials as the standard for go/no-go decisions](https://onco.cc/ideas/idea-tr2-multilab-preclinical/), [Run the mouse or organoid trial at the same time as the human trial](https://onco.cc/ideas/idea-bio1-co-clinical-avatar-trials/), [Test drugs on the patient's own cancer cells when there is no trial to join](https://onco.cc/ideas/idea-bio2-functional-precision-rare/)
- roadmaps: [Drug discovery roadmap: screening in mice → maps of dependency → designing in silico](https://onco.cc/roadmaps/drug-discovery-roadmap/)

---
JSON: https://onco.cc/api/v1/entities/champions-oncology.json